Dr. Moulton is Director of Pediatric Trauma and Burn Services at Children’s Hospital Colorado and Professor of Surgery at the University of Colorado, School of Medicine. He received his MD degree from the University of Washington in 1986. He trained in General Surgery at the University of California, San Diego and in Pediatric Surgery at the State University of New York, Brooklyn. He is board certified in General and Pediatric Surgery. He has authored or co-authored more than 100 peer-reviewed articles and 15 book chapters. Dr. Moulton is the State of Colorado Vice-Chair for the American College of Surgeons, Committee on Trauma (ACS COT). Dr. Moulton's research efforts span the fields of trauma and burn care, fluid resuscitation, hemodynamic monitoring and medical device development. He is an inventor on 4 issued and 11 pending U.S. patents.
Kiernan has led revenue growth and business operations at category-leading organizations throughout his career. Most recently, he served as President & CEO, DripDrop Hydration, a medical grade rehydration product. While there, he led multi-channel commercialization focused on the DoD, national retail, medical opinion leaders and elite athletes. He has also held senior executive roles at Kaplan/The Washington Post, Common Sense Media and GreatSchools. Kiernan has served as an advisor for numerous startups and environmental literacy nonprofits, including Ten Strands and Dashboard Earth. Kiernan has a BA from The College of the Holy Cross and a Masters from Boston University.
Jennifer brings over 20 years of experience providing strategic leadership to deliver operational excellence. She values high-performing cultures that empower individuals to bring a creative, analytical, and collaborative approach to problem-solving. Previously, Jennifer served as COO at Cytovale, a company developing a more rapid and insightful way to diagnose sepsis. While there, she led clinical operations, marketing, program management, strategy, and business development. Jennifer formerly held leadership roles, both domestically and abroad, at Abbott, Guidant, Health+Commerce and 3M, and she has advised multiple early stage and Fortune 500 companies. Jennifer is a founding member of MedtechWomen. She holds a BS in Chemical Engineering from University of Michigan and an MBA from Harvard Business School.
John joins Flashback with over 20 years of technology and new product development experience, including 10 years working on FDA regulated medical device products for startups and R&D groups of Fortune 500 companies. John has leveraged his management and technical expertise to lead product development for wearable sensors, machine learning, and other advanced electronic and software components. John’s prior experience includes SVP Product Strategy and Development for Symphony Teleca (acquired by Harman International Industries), CIO of Spotlight Health, and Manager at Deloitte Consulting. John has a BS degrees in Electrical Engineering and Information and Computer Science from UC Irvine, and an MBA from the Anderson Graduate School of Management at UCLA.
A pediatric hospital medicine specialist and physician executive with over 30 years of clinical and administrative experience, Dr. Melzer’s career has included executive roles in strategic planning, business development, managed care, institutional partnerships, physician practice management, and population health. At Seattle Children’s, he was the SVP and Chief Strategy Officer between 2005 and 2015, and Executive Vice President from 2015-2019.
Dr. Melzer has served as an advisor and consultant to many leading adult and children’s health care systems in the US and internationally. After leaving Seattle Children’s in November 2019, he was appointed as the Senior Advisor to the Children’s Hospital Association, a trade and advocacy group representing over 250 pediatric facilities. In this role, he convenes groups of national experts to identify and disseminate industry best practices and advises leadership teams on emerging trends in health care. A leader in community non-profit management, he currently serves as a Board member and advisor at PATH in Seattle, one of the largest international NGOs in the US.
Dr. Melzer received his MD degree from Mt. Sinai School of Medicine in New York and MBA at the University of Washington. He is a retired Professor of Pediatrics at the UW School of Medicine and Adjunct Professor of Health Services in the UW School of Public Health. Sandy divides his time between Seattle and Lopez Island, Washington, pursuing his interests in community board work, bicycling, and sailing in the San Juan islands.
Dr. DelloRusso has 20+ years of experience in product, business and funding strategy of for- and non-profit ventures in healthcare and the life sciences, and currently works with startups to public companies. She was a Partner at Providence Ventures, the strategic venture capital arm of Providence St. Joseph Health, where she led the fund’s investments in Omada Health, Lyra Health and N-of-One. Prior to Providence she was the Managing Director of WINGS, a medical-technology angel investment group, and the VP of Commercialization for Life Science Washington, the state’s industry trade association. She also spent time as an independent grants consultant, non-profit Program Manager, postdoctoral researcher and business owner. She received her PhD in Physiology from the University of Michigan and completed postdoctoral studies at the University of Washington and Children’s Hospital Boston/Harvard Medical School.
Vera Tice is a board director and global strategic advisor in healthcare innovation and technology. She has held senior executive and research and development (R&D) engineering leadership positions in the healthcare technology and diagnostics, medical device, and mobile telecommunications industries, including COO, VP, and Managing Director. Companies include Quest Diagnostics (DGX), Hewlett-Packard Medical (now Philips) (HP), Nokia (NOK), Enmar Health, and HealthWyse (now Net Health), along with heading up the Healthcare Delivery Institute at Worcester Polytechnic Institute. Vera holds a BEng and MS in Electrical and Computer Engineering from Stevens Institute of Technology and Worcester Polytechnic Institute, respectively.
Vera holds a Board Director role with VNA Care, is an industry advisor to Silverwood Partners, and serves as an international expert panel member to several global and national organizations investing in advancing healthcare and improving human health. She is a founding member of the New England Chapter of the Private Directors Association (PDA) and a mentor in their Private Company Governance Certificate program. She previously served as an advisor to the Wellcome Trust (UK), advisory board member to Partners Healthcare (Mass General Brigham) and Stevens Institute of Technology, and advisor to the Massachusetts Technology Transfer Center.
David Zezza is a founding member of Pacific Advantage Capital and is involved with the group’s activities in the US, Europe, and Asia. David co-founded PAC in 2010 after his time at Citadel Investment Group based in Chicago and London, where as a Senior Managing Director he oversaw the firm’s Global Rates and Emerging Markets businesses. Prior to Citadel, he worked with Deutsche Bank in London, Hong Kong, and Singapore, where he was a member of the Management Committee and Global Head of Emerging Markets for the firm. Prior to Deutsche Bank, he spent 10 years at Salomon Brothers in the US and Asia.
David is a member of the UK Board of Trustees for the Global Fund for Children. He also serves on the Board of Advisors of the Sanford School at Duke University. He received an AB in Economics and Public Policy Studies from Duke University, graduating Magna Cum Laude.
Raised in Seattle, Mike attended Brown University and the University of Washington, where he received his MD. Mike practiced Emergency Medicine for 20 years, during which time he ran a clinical practice and managed a group of Emergency Physicians.
Mike is active in the bioscience start-up community as a Scientific Advisor, Corporate Advisor, Board member and investor. Mike is co-chairing the University of Washington’s 5 Billion campaign. He is a Past President of Seattle Academy of Arts and Sciences (SAAS) and was a founding member of numerous 501c3's.
Terri Burke is a Venture Partner with Epidarex Capital, where she leads the MedTech investment strategy. She is also co-founder and CEO of Protaryx Medical. Previously, Terri was a member of the Senior Leadership Team at Edwards Lifesciences and held multiple Vice President positions in the heart valve business, including managing a cross-functional technical development program, leading Global Marketing, and overseeing Business Development for several strategic acquisitions and partnerships. Terri has prior experience in health economics and reimbursement as a consultant with Covance and in product marketing with Guidant Corporation.
Terri holds a Board Director role with Raydiant Oximetry and Flashback Technologies, is a founding member of MedtechWomen and serves as a founding member of the Duke University Women’s Impact Network Athletics Council. Terri acts as an advisor for Ignite Healthcare, serves as the lifesciences chair for the TRANSFORM program with Duke’s Innovation & Entrepreneurship Initiative, and participates in a working group with FDA and industry leaders that is drafting a framework to enhance the pediatric medical device innovation ecosystem. Terri holds a BS in Biology from Duke University and an MBA from the University of Southern California.
Dr. Jaquiss is the Chief of Congenital Heart Surgery at Children’s Medical Center/UT Southwestern in Dallas. He formerly held similar positions at Duke University and the University of Arkansas. He is a graduate of Wabash College and Vanderbilt University School of Medicine, and did his postgraduate training in surgery, cardiothoracic surgery, and pediatric cardiothoracic surgery at Washington University in St. Louis/St. Louis Children’s Hospital. As a practicing congenital heart surgeon with nearly 25 years of experience, he has a long interest in neonatal heart surgery and the surgical treatment of heart failure with transplant and mechanical circulatory support.
Melissa Cruz is a board director and qualified financial expert with industry expertise at the intersection of technology and healthcare. She previously served as board director and audit committee chair for eSolutions and board director for N-of-One. She is a five-time Chief Financial Officer for companies in technology, healthcare, and their intersection point. Companies include Concord Communications (CCRD) (now CA), BladeLogic (now BMC), Picis (now Optum), Progress Software (PGRS) and N-of-One (now Qiagen).
Melissa is a member of the Board of Trustees of Lahey Medical Center (LMC), and a member of the Compliance and Audit Committee of Beth Israel Lahey Health (BILH). She also serves as a strategic board advisor and executive coach to Jambb, Inc. a token and equity funded blockchain and NFT software solution.
She holds a BS in Finance from Boston College, a MS in Management from Lesley University and is currently enrolled in Graduate Certificate in Executive Coaching program at William James.
LTG Walker graduated from the US Military Academy in 1976 and Harvard Business School in 1984. He served as armor and cavalry officer for over 38 years, culminating as the Director of the U.S. Army Capabilities Integration Center. Walker’s assignments included senior leadership and management positions in U. S. Army and Joint and Combined Forces, with thirteen years in operational assignments with U. S. partners in Iraq, Kuwait, Kosovo, Bosnia, Germany, and Belgium. He currently serves on the faculty of Thayer, teaching leadership to corporate executives; is a strategic advisor to start-up companies; and serves on the board of advisors for Israeli Aerospace Industries – North America.
Sarah is a partner at Artegis Law Group, where she focuses her practice on building patent portfolios for companies in the high tech industry. Sarah advises a broad range of clients, from early stage startups to Fortune 100 companies, on protecting their intellectual property with an eye towards value creation and current and future market relevance. Her strong technical background, stemming from her rigorous academic training at MIT and practical experience as a software engineer, combined with her extensive legal experience uniquely position her to handle even the most complex technical and legal problems. Sarah received an SB in Computer Science from MIT and a JD, with highest honors, from Santa Clara University.
Bob is a health care executive with a varied background in complex teaching, urban and rural health care settings. During his 40-year career in the industry he has held Chief Executive Officer and other executive positions at various for profit and non-profit hospitals and health care organizations, where he demonstrated his ability to turnaround, create and grow business units in complex and competitive environments. He received his undergraduate degree from the University of Missouri and a graduate degree from Washington University in St. Louis.
Karri brings more than two decades working for and with the U.S. Government (Department of Defense, U.S. Air Force, the Intelligence Community and NASA). She started her career as a U.S. Air Force judge advocate where she supported major defense programs, base operational contracting, and international and joint war operations. She gained additional expertise working at a major D.C. law firm on a variety of government contracting matters. She has served as the Chief Operating Officer and General Counsel for Special Aerospace Services, a certified 8(a) woman-owned small business.
As a Senior Managing Director in the San Francisco office of Guidepost Solutions, Stephanie focuses on sensitive internal and white collar crime investigations, building corporate compliance programs, intellectual property protection and national security consulting, including CFIUS matters. She has extensive experience in the management and oversight of both criminal and national security investigations and domestic and global security operations and policy development. Stephanie has enjoyed a distinguished career in both the private and public sectors, including Special Agent in Charge for the FBI’s San Francisco Division. She retired as a Senior Executive from the Federal Bureau of Investigations (FBI), where she served in a variety of influential roles, including overseeing FBI’s national security operations, the Deputy Assistant Director, and Counter intelligence an Chief Intelligence Officer.
Paul has been in the medical device industry since 1975. He was President of Dryden Corporation, an anesthesia / respiratory disposable manufacturer until it was sold to Louis Gibeck AB in 1988. He remained as President until 1992, when he left to form ProMedic. Paul has a BS from Purdue University, West Lafayette, IN, and an MBA from Butler University, Indianapolis, IN. He has been active in a number of medical device associations and is active in the ASTM / AAMI standards committees for anesthesia / respiratory devices. Paul currently serves on a number of company Boards and serves as a senior advisor for several clients.
Paul is a member of the University of Colorado School of Medicine, Division of Pulmonary Sciences and Critical Care Medicine Research Board. He is also a member of the ASTM Pulse Oximetry Working Group, where he functioned as Designated United States Expert and representative to the International Standards Organization. He was actively involved in the development of the current International Standard for Pulse Oximetry (9919).
Paul formerly managed a clinical research grant that developed Non-invasive ventilatory support systems for use in the Critical Care arena. Prior to that, he instituted Pulmonary Function Laboratories and Respiratory Therapy Departments in several hospitals. He has a number of medical publications to his credit, and has lectured in clinical and collegiate settings throughout the US and Europe.